11
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      COVID-19 Vaccine Booster Hesitancy (VBH) among Healthcare Professionals of Pakistan, a Nationwide Survey.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: The waning vaccine immunity and emergence of new variants of SARS-CoV-2 led health authorities across the globe to administer booster doses (BDs) of the COVID-19 vaccine. Hence, the current study aimed to assess the COVID-19 vaccine booster hesitancy (VBH) amongst Pakistani healthcare professionals (HCPs). Methods: A nationwide survey-based study was carried out from April 2022 to May 2022. The online self-administered questionnaire was utilized to collect data regarding demographics (age, gender, marital status, profession, residential area, and province), COVID-19 infection history (infection history, onset, and clinical severity of disease), previous COVID-19 vaccination (type of vaccination and the number of doses), attitudes towards BDs (acceptance, rejection, and hesitancy), and psychological drivers of VBH (perceived effectiveness, vaccine safety, risk/benefit ratio, and vaccine type preference). We assessed the association between the dependent variable attitudes of study participants, regarding BDs and independent variables (demographics, COVID-19 infection history, previous COVID-19 vaccination, and psychological drivers of VBH), by using the Chi-square test/Fisher exact test. Results: Among the 1164 study participants, 51.4% were male, and 80.4% were medical professionals. The half of study participants (52.1%) agreed to take the COVID-19 vaccine BD or had already taken it, while the rest of them refused (34.7%) or hesitated (24.2%) to take it. These attitudes of the participants were significantly associated (p < 0.001) with psychological divers about the COVID-19 vaccine BD. Conclusion: This study revealed that Pakistani HCPs hesitant to take the COVID-19 vaccine BD had concerns about the safety, efficacy, and risk/benefits ratio of the vaccine’s BD. To eliminate the hesitancy, regarding BD in HCPs, certain educational strategies should be implemented by health authorities to address the concerns of HCPs.

          Related collections

          Author and article information

          Journal
          Vaccines (Basel)
          Vaccines
          MDPI AG
          2076-393X
          2076-393X
          Oct 17 2022
          : 10
          : 10
          Affiliations
          [1 ] Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.
          [2 ] Department of Pharmacy, Southern Punjab Institute of Health Sciences, Multan 60000, Pakistan.
          [3 ] Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.
          [4 ] Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.
          [5 ] University College of Pharmacy, Allama Iqbal Campus, University of the Punjab, Lahore 54000, Pakistan.
          [6 ] Department of Political Science, Bahauddin Zakariya University, Multan 60800, Pakistan.
          [7 ] School of Economics, Bahauddin Zakariya University, Multan 60800, Pakistan.
          Article
          vaccines10101736
          10.3390/vaccines10101736
          9610760
          36298600
          605342d9-db74-4c1f-95b9-ed2fc81dc3dd
          History

          COVID-19 vaccines,Pakistan,booster dose,vaccine acceptance,vaccine hesitancy

          Comments

          Comment on this article